Cantor Fitzgerald Initiates Coverage on HCP (NYSE:HCP). What May be Next?

August 8, 2018 - By Paula Hilliard

HCP, Inc. (NYSE:HCP) Logo

Investors sentiment increased to 1 in 2018 Q1. Its up 0.11, from 0.89 in 2017Q4. It is positive, as 57 investors sold HCP, Inc. shares while 154 reduced holdings. 53 funds opened positions while 158 raised stakes. 399.33 million shares or 0.65% less from 401.93 million shares in 2017Q4 were reported.

Atlantic Tru Ltd Liability holds 461 shares or 0% of its portfolio. 34,510 were accumulated by Shell Asset Comm. Rhumbline Advisers has invested 0.04% in HCP, Inc. (NYSE:HCP). Pictet Asset Management has 263,011 shares. Gam Ag reported 0.01% stake. Brown Advisory, Maryland-based fund reported 61,727 shares. Natixis Advisors Limited Partnership owns 172,837 shares. Dupont Capital Mgmt owns 104,040 shares or 0.06% of their US portfolio. Wendell David reported 19,000 shares. Keybank Association Oh reported 34,520 shares or 0% of all its holdings. Mengis Cap Inc reported 0.22% of its portfolio in HCP, Inc. (NYSE:HCP). Principal, a Iowa-based fund reported 4.17 million shares. Ameriprise holds 0.01% of its portfolio in HCP, Inc. (NYSE:HCP) for 757,077 shares. Macroview Llc holds 229 shares. Fmr Limited Liability Corporation has 0% invested in HCP, Inc. (NYSE:HCP) for 288,414 shares.

Since February 13, 2018, it had 2 insider purchases, and 0 sales for $808,919 activity. The insider Griffin R Kent Jr bought 21,100 shares worth $502,180.

Why Has Cantor Fitzgerald Given HCP (NYSE:HCP) a $28 Price Target

Equities researchers at Cantor Fitzgerald has initiated coverage on shares of HCP (NYSE:HCP) in analysts note issued to clients on 8 August. The broker set “Neutral” rating on the stock. Cantor Fitzgerald’s TP of $28 suggests potential of 7.32 % from the stock’s last price.

HCP, Inc. (NYSE:HCP) Ratings Coverage

Among 11 analysts covering HCP Inc (NYSE:HCP), 3 have Buy rating, 2 Sell and 6 Hold. Therefore 27% are positive. HCP Inc has $28 highest and $21 lowest target. $25.13’s average target is -3.68% below currents $26.09 stock price. HCP Inc had 13 analyst reports since February 13, 2018 according to SRatingsIntel. The stock of HCP, Inc. (NYSE:HCP) earned “Buy” rating by Stifel Nicolaus on Wednesday, February 14. Stifel Nicolaus maintained the shares of HCP in report on Monday, August 6 with “Buy” rating. Morgan Stanley maintained HCP, Inc. (NYSE:HCP) rating on Thursday, June 14. Morgan Stanley has “Equal-Weight” rating and $23.5 target. The firm has “Hold” rating given on Monday, May 21 by Raymond James. On Tuesday, March 20 the stock rating was maintained by Wells Fargo with “Market Perform”. The rating was maintained by Mizuho with “Buy” on Thursday, February 15. The firm has “Buy” rating by Bank of America given on Thursday, March 8. The firm earned “Sell” rating on Wednesday, February 21 by UBS. The stock of HCP, Inc. (NYSE:HCP) earned “Underperform” rating by Evercore on Monday, May 21. Robert W. Baird maintained it with “Hold” rating and $24.0 target in Thursday, February 15 report.

The stock decreased 1.44% or $0.38 during the last trading session, reaching $26.09. About 1.63M shares traded. HCP, Inc. (NYSE:HCP) has declined 25.43% since August 8, 2017 and is downtrending. It has underperformed by 38.00% the S&P500.

Analysts await HCP, Inc. (NYSE:HCP) to report earnings on November, 1. They expect $0.44 earnings per share, down 8.33 % or $0.04 from last year’s $0.48 per share. HCP’s profit will be $209.65 million for 14.82 P/E if the $0.44 EPS becomes a reality. After $0.47 actual earnings per share reported by HCP, Inc. for the previous quarter, Wall Street now forecasts -6.38 % negative EPS growth.

HCP, Inc. is an independent hybrid real estate investment trust. The company has market cap of $12.43 billion. The fund invests in real estate markets of the United States. It has a 202.25 P/E ratio. It primarily invests in properties serving the healthcare industry including sectors of healthcare such as senior housing, life science, medical office, hospital and skilled nursing.

More news for HCP, Inc. (NYSE:HCP) were recently published by:, which released: “HCP boosts year adjusted FFO guidance, reaffirms SPP cash NOI view” on August 02, 2018.‘s article titled: “HCP forms $605M medical office joint venture with Morgan Stanley” and published on August 02, 2018 is yet another important article.

HCP, Inc. (NYSE:HCP) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.